EXETER, N.H.--(BUSINESS WIRE)--Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical company, announced today it has engaged Sharon Merrill Associates, Inc. to support its investor relations and corporate communications efforts. Based in Boston, Sharon Merrill Associates (SMA) is a nationally recognized investor relations and corporate communications consulting firm.
